Clinical trial
MARIS Study; Mediterranean Approach to Reduce Insulin-Resistance Study
NCT00405197 · Wageningen University, Other · Completed
Key facts
| NCT number | NCT00405197 |
|---|---|
| Title | MARIS Study; Mediterranean Approach to Reduce Insulin-Resistance Study |
| Official title | Study on the Effect of Mono-Unsaturated Fatty Acids (MUFA) and the Mediterranean Diet on Hyperinsulinemia and Other Components of the Metabolic Syndrome |
| Lead sponsor | Wageningen University, Other |
| Collaborators | Netherlands Heart Foundation Unilever R&D Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Insulin Resistance, Metabolic Syndrome X, Dyslipidemia, Hypertension, Overweight |
| Intervention type | Behavioral |
| Interventions | Isocaloric diet high in MUFA or Mediterranean diet |
| Enrollment | 60 |
| Start date | Nov 1, 2006 |
| Completion | Apr 1, 2007 |
| First posted | Nov 29, 2006 |
| Last update posted | Dec 12, 2007 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: